Label: GUAIFENESIN liquid
- NDC Code(s): 83720-503-16
- Packager: Oncor Pharmaceuticals
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated May 10, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each 5 mL teaspoonful)
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- cough that occurs with too much phlegm (mucus)
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
-
Directions
- do not take more than 6 doses in any 24-hour period
Age Dose Adults and Children 12 years and over 2-4 Teaspoonfuls every 4 hours Children 6 years to under 12 years 1-2 Teaspoonfuls every 4 hours Children 2 years to under 6 years 1/2-1 Teaspoonful every 4 hours Under 2 years Ask a doctor
Drug Facts(continued)
- do not take more than 6 doses in any 24-hour period
- Other information
- Inactive ingredients
- Questions?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GUAIFENESIN
guaifenesin liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83720-503 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 100 mg in 5 mL Inactive Ingredients Ingredient Name Strength CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) FD&C RED NO. 40 (UNII: WZB9127XOA) GLYCERIN (UNII: PDC6A3C0OX) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) SODIUM BENZOATE (UNII: OJ245FE5EU) SODIUM CITRATE (UNII: 1Q73Q2JULR) SODIUM (UNII: 9NEZ333N27) SORBITOL SOLUTION (UNII: 8KW3E207O2) SUCRALOSE (UNII: 96K6UQ3ZD4) Product Characteristics Color Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83720-503-16 473 mL in 1 BOTTLE; Type 0: Not a Combination Product 05/10/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 05/10/2024 Labeler - Oncor Pharmaceuticals (119032580) Registrant - Oncor Pharmaceuticals (119032580)